Related Experiment Video
Updated: Jan 7, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Beyond the left ventricle: Right ventricular dysfunction as a critical determinant in type 1 diabetes-related
Tong-Jian Zhao1, Nian-Zhe Sun2,3
1Joslin Diabetes Center, Harvard Medical School, Boston, MA 02215, United States.
Insights
Diabetic cardiomyopathy affects both ventricles, with early diastolic dysfunction preceding systolic decline in the left ventricle. The right ventricle also shows age-related changes, including fibrosis and pulmonary hypertension.
Area of Science:
- Cardiology
- Endocrinology
- Pathology
Background:
- Diabetic cardiomyopathy (DCM) is traditionally viewed as a left ventricular (LV) disease.
- Emerging evidence indicates the right ventricle (RV) is also impacted by diabetes, potentially causing adverse outcomes.
Abstract:
Diabetic cardiomyopathy (DCM) has long been considered as a left ventricular (LV) disease with diastolic dysfunction preceding systolic dysfunction in diabetes. However, it is increasingly recognized that the right ventricle (RV) is also affected by diabetes and may be independently responsible for adverse outcomes in diabetic patients with or without LV failure. Yu et al conducted a 30-week longitudinal evaluation of biventricular function and pathology in OVE26 diabetic mice and revealed early diastolic dysfunction preceding systolic decline, suggesting that early LV diastolic impairment precedes the later onset of systolic dysfunction. With age, the animals developed fibrosis, hypertrophy, and pulmonary arterial hypertension in the RV. The purpose of this editorial is to contextualize these findings within the existing literature by highlighting the interplay between cardiac chambers and the vasculature. We also seek to reiterate that DCM is a condition extending beyond left ventricular dysfunction. As the authors note, the right side of the heart may remain "the forgotten ventricle" in diabetic patients. We hope that the mechanisms discussed in this paper will help researchers to understand the pathogenesis of cardiovascular disease in this context and encourage clinicians to be more attentive to the associated clinical symptoms.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Mitral Regurgitation I: Introduction

